12 Pharmacy completes first close of Series A for veterinary dispensing
Shinhan-GB FutureFlow Fund, Shizuoka Capital and pipon back pharmacy expansion, new dispensing products and delivery improvements.
12 Pharmacy announced the first close of its Series A on January 14, 2026. Investors were Shinhan-GB FutureFlow Fund, Shizuoka Capital and pipon. The amount was not disclosed. Global Brain, which jointly manages the fund with Shinhan Venture Investment, confirmed its lead-investor role.
The company planned to expand pharmacies near veterinary hospitals, develop new dispensing products and improve delivery operations. At the announcement, it said more than 320 hospitals were using its services.
The investment supports an outsourced dispensing model in which veterinary hospitals send prescription instructions to pharmacists, allowing clinical staff to focus on consultations. Global Brain cited the opportunity to reduce workload at hospitals and waiting times for pets and owners.
Use of funds
Expand pharmacies near veterinary hospitals
Develop new dispensing products
Improve delivery operations